BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares logo

BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares (BMGCX)

Market Closed
11 Aug, 20:00
NASDAQ NASDAQ
$
16. 27
+0.14
+0.8679%
$
4.33B Market Cap
- Div Yield
0 Volume
$ 16.13
Previous Close
Add Transaction
Day Range
16.27 16.27
Year Range
15.07 27.06
Want to track BMGCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BMGCX closed today higher at $16.27, an increase of 0.8679% from yesterday's close, completing a monthly decrease of -26.8106% or -$5.96. Over the past 12 months, BMGCX stock lost -17.6619%.
BMGCX pays dividends to its shareholders, with the most recent payment made on Jul 23, 2026. The next estimated payment will be in In 5 months on Jan 23, 2027 for a total of $5.26805.
The stock of the company had never split.
The company's stock is traded on one exchange.

BMGCX Chart

BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares (BMGCX) FAQ

What is the stock price today?

The current price is $16.27.

On which exchange is it traded?

BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares is listed on NASDAQ.

What is its stock symbol?

The ticker symbol is BMGCX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.33B.

Has BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares ever had a stock split?

No, there has never been a stock split.

BlackRock Mid-Cap Growth Equity Portfolio Investor C Shares Profile

NASDAQ Exchange
US Country

Overview

The company is focused on providing investment opportunities by primarily allocating its assets in equity securities of U.S. mid-capitalization companies. It aims to invest in those entities that exhibit above-average earnings growth potential, carefully selected by fund management based on their promising future prospects. The firm uses the Russell Midcap® Growth Index as a benchmark to define the size of the mid-capitalization companies it targets. This strategic approach is designed to cater to investors seeking growth through investments in the mid-cap segment of the market, which is often perceived to hold a unique blend of growth potential and risk mitigation when compared to their small-cap and large-cap counterparts.

Products and Services

  • Equity Securities of U.S. Mid-Capitalization Companies

This product focuses on investing in the common stocks of U.S. mid-capitalization companies that are believed to have above-average earnings growth potential. These companies are generally comparable in size to those listed in the Russell Midcap® Growth Index. The selection process emphasizes identifying companies that show promising growth trajectories, making it a suitable option for investors interested in growth-focused mid-cap investments.

  • Preferred Stock and Convertible Securities

In addition to common stocks, the company offers investment opportunities in preferred stock and convertible securities. Preferred stocks provide a potential for steady income through dividends, while convertible securities offer the flexibility to convert into a predetermined number of common shares, typically at the option of the holder. This diversification enables investors to balance their portfolios by incorporating assets that may offer a blend of income and growth, along with the potential for capital appreciation.

  • Other Equity Securities

Expanding beyond the traditional investment avenues, the company also explores opportunities in other equity securities that might fit the investment criteria of growth and potential. This may include warrants, purchase rights, and other securities that could provide an alternative route to achieving the fund’s growth objectives. By offering a broader array of investment options, the company aims to cater to a wide range of investor preferences, making it a versatile choice for those looking to diversify their investment portfolios with mid-cap equity securities.

Contact Information

Address: 100 Bellevue Parkway
Phone: 800-441-7762